EDGAR Filing Documents for 0001193125-18-010089

Form SC 13D - General statement of acquisition of beneficial ownership:

SEC Accession No. 0001193125-18-010089

Filing Date

2018-01-12

Accepted

2018-01-12 16:46:33

Documents

Group Members

TAKEDA A/STAKEDA EUROPE HOLDINGS B.V.TAKEDA PHARMA A/STAKEDA PHARMACEUTICALS INTERNATIONAL AG

Document Format Files

Seq	Description	Document	Type	Size
1	SC 13D	d521799dsc13d.htm	SC 13D	154831
2	EX-99.1	d521799dex991.htm	EX-99.1	196124
3	EX-99.2	d521799dex992.htm	EX-99.2	84454
4	EX-99.3	d521799dex993.htm	EX-99.3	32972
5	EX-99.4	d521799dex994.htm	EX-99.4	32164
6	EX-99.5	d521799dex995.htm	EX-99.5	34874
7	EX-99.6	d521799dex996.htm	EX-99.6	8772
8	EX-99.7	d521799dex997.htm	EX-99.7	11756
9	EX-99.8	d521799dex998.htm	EX-99.8	14414
10	EX-99.9	d521799dex999.htm	EX-99.9	11715
11	EX-99.10	d521799dex9910.htm	EX-99.10	11490
12	EX-99.11	d521799dex9911.htm	EX-99.11	13337
13	GRAPHIC	g521799g38x80.jpg	GRAPHIC	3985
	Complete submission text file	0001193125-18-010089.txt		614061

Mailing Address 1-1, DOSCHOMACHI 4-CHOME CHUO-KU, OSALCA 540-8645 M0 00000

Business Address 1-1, DOSCHOMACHI 4-CHOME CHUO-KU, OSALCA 540-8645 M0 00000

TAKEDA PHARMACEUTICAL CO LTD (Filed by) CIK: 0001395064 (see all company filings)

IRS No.: 000000000
Type: SC 13D

Mailing Address ROMEINSE STRAAT 12 BOX 2, 3001 LEUVEN C9 0000000

Business Address ROMEINSE STRAAT 12 BOX 2, 3001 LEUVEN C9 0000000 34918060946

TiGenix NV (Subject) CIK: 0001581987 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C9
Type: SC 13D | Act: 34 | File No.: 005-89730 | Film No.: 18526386
SIC: 2834 Pharmaceutical Preparations